CROSARA, Serena
 Distribuzione geografica
Continente #
NA - Nord America 1.998
AS - Asia 1.652
EU - Europa 1.117
SA - Sud America 230
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 5.074
Nazione #
US - Stati Uniti d'America 1.965
SG - Singapore 681
CN - Cina 516
IT - Italia 336
BR - Brasile 191
IE - Irlanda 191
SE - Svezia 163
HK - Hong Kong 128
VN - Vietnam 103
DE - Germania 76
TR - Turchia 71
FI - Finlandia 62
NL - Olanda 60
ZA - Sudafrica 56
FR - Francia 44
GB - Regno Unito 44
AT - Austria 32
RU - Federazione Russa 28
BD - Bangladesh 27
IN - India 21
BE - Belgio 20
IR - Iran 20
KR - Corea 18
UA - Ucraina 18
JP - Giappone 17
AR - Argentina 15
MX - Messico 14
CA - Canada 13
CH - Svizzera 8
PL - Polonia 8
ID - Indonesia 7
TW - Taiwan 7
HU - Ungheria 6
CO - Colombia 5
EC - Ecuador 5
IQ - Iraq 5
MA - Marocco 5
ES - Italia 4
PH - Filippine 4
PY - Paraguay 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
PE - Perù 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CL - Cile 2
EE - Estonia 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
NO - Norvegia 2
OM - Oman 2
PK - Pakistan 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.074
Città #
Singapore 344
Ashburn 284
Dallas 265
Chandler 207
Dublin 191
Santa Clara 168
Beijing 143
Hong Kong 128
Ann Arbor 109
Boardman 71
Chicago 63
Izmir 61
Dearborn 58
Los Angeles 58
Johannesburg 53
Parma 47
Nanjing 45
Ho Chi Minh City 39
Milan 37
Princeton 36
Shanghai 33
Hefei 32
Vienna 27
Hanoi 24
São Paulo 24
Shenyang 22
Wilmington 22
New York 21
Bremen 20
Brussels 19
Munich 18
Buffalo 16
Columbus 15
Marseille 15
Tokyo 15
Kunming 14
London 14
Hebei 13
Moscow 12
Sant'ilario D'enza 12
Changsha 11
Jinan 11
Mountain View 11
Rome 11
San Mateo 11
Council Bluffs 10
Fremont 10
Jacksonville 10
Seattle 10
Frankfurt am Main 9
Helsinki 9
Nanchang 9
Woodbridge 9
Zanjan 9
Denver 8
Guangzhou 8
Jiaxing 8
Tianjin 8
Atlanta 7
Gangnam-gu 7
Mexico City 7
Monza 7
San Jose 7
The Dalles 7
Warsaw 7
Zhengzhou 7
Brescia 6
Des Moines 6
Jakarta 6
Ningbo 6
Phoenix 6
Pignone 6
Stockholm 6
Vicopisano 6
Washington 6
Abano Terme 5
Ankara 5
Bougligny 5
Chengdu 5
Da Nang 5
Genoa 5
Montreal 5
Poplar 5
Preston City 5
San Francisco 5
Seoul 5
Zurich 5
Amsterdam 4
Belo Horizonte 4
Brasília 4
Chennai 4
Dhaka 4
Düsseldorf 4
Giovinazzo 4
Hangzhou 4
Hải Dương 4
Jundiaí 4
Lviv 4
Mumbai 4
Nuremberg 4
Totale 3.189
Nome #
Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs 224
Normal aortic annulus dimensions in Boxer dogs according to sex and body weight 207
Aorto-septal angle, isolated basal septal hypertrophy and systolic murmurs in 122 cats 173
DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study 164
Aorto-septal angle and systolic murmur in apparently healthy cats: a pilot study 157
Transthoracic echocardiography in clinically healthy adult Newfoundland dogs: reference values for the breed 154
Tetralogia di Fallot in un gatto 137
Systolic Arterial Pressure Measured Simultaneously by Doppler Technique, Using Forelimb and Hindlimb in Dogs 133
Effect of sampling time on urinary electrolytes following oral furosemide administration in dogs with myxomatous mitral valve disease 131
Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker of Acute Kidney Injury (AKI) in Dogs with Congestive Heart Failure (CHF) Due to Myxomatous Mitral Valve Disease (MMVD) 128
The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study 127
Slow ventricular response atrial fibrillation and J wave in a hypothermic dog 121
ECG of the month 116
Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease 116
Corner Diagnostico di Cardiologia 114
Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease 111
Effect of the sampling time on urinary electrolytes following furosemide administration in dogs with myxomatous mitral valve disease 108
Migration of a Kirschner wire to the heart in a Yorkshire terrier 105
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 104
Anatomic distribution and electrophysiologic properties of accessory atrioventricular pathways in dogs 103
Aorto-septal angle, isolated basal septal hypertrophy, and systolic murmur in 122 cats 102
Diagnostic performance of P wave duration in the identification of left atrial enlargement in dogs 99
Endocardite batterica 96
Overview on antimicrobial prescription habits in cats at different clinical services of the Veterinary Teaching Hospital of Parma 94
The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (LOOK-Mitral registry): Baseline characteristics 93
The longitudinal outcome of canine (K9) myxomatous mitral valve disease (LOOK-Mitral) registry: Baseline treatment characteristics 93
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 92
Holter monitoring in 36 dogs with myxomatous mitral valve disease 88
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 88
Association between echocardiographic indexes and urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in dogs with myxomatous mitral valve disease 87
Holter monitoring in dogs with mitral regurgitation and different class of heart failure 87
An Observational Study on the Diagnosis and Antibiotics Prescription in Cats with Lower Urinary Tract Disease by Veterinarians in Italy 84
Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease 82
Miocardiopatie del cane 81
Screening for subaortic stenosis in Boxers in Italy 81
La malattia valvolare mitralica nel cane 80
Preliminary investigation of cardiovascular-renal disorders in dogs with chronic mitral valve disease 78
Radiofrequency catheter ablation of concealed accessory pathways in two dogs with symptomatic atrioventricular reciprocating tachycardia 78
Systolic arterial pressure measured simultaneously by Doppler technique, using forelimb and hindlimb, in dogs 76
Insufficienza cardiaca: fisiopatologia e principi di terapia 74
Malattia cronica mitralica 74
Use of contrast echocardiography for quantitative and qualitative evaluation of myocardial perfusion and pulmonary transit time in healthy dogs 73
Survival Characteristics and Prognostic Variables of Dogs with Preclinical Chronic Degenerative Mitral Valve Disease Attributable to Myxomatous Degeneration 73
Suspected Drinking Water Poisoning in a Domestic Kitten with Methemoglobinemia 71
Left atrial volume and function in Cavalier King Charles spaniels at different ACVIM stages 70
Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve Disease 69
Utility of 12-Lead Electrocardiogram for Differentiating Paroxysmal Supraventricular Tachycardias in Dogs 66
Natural history and risk predictors of chronic degenerative mitral valve disease in asymptomatic dogs 61
Bradyarrhythmia after treatment with atenolol and mirtazapine in a cat with hypertrophic cardiomyopathy 57
Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease 55
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 43
Totale 5.178
Categoria #
all - tutte 19.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 13 4 15 29 17 7 6
2021/2022231 33 5 6 14 11 2 6 26 7 15 33 73
2022/2023833 68 84 60 68 69 89 12 63 253 21 24 22
2023/2024466 29 33 23 17 35 97 24 42 22 39 18 87
2024/20251.236 51 49 62 127 141 137 58 50 184 88 68 221
2025/20261.605 222 213 444 222 379 125 0 0 0 0 0 0
Totale 5.178